SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
刘步遥
Lv1
30 积分
2024-04-16 加入
最近求助
最近应助
互助留言
Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance
13天前
已完结
Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus
13天前
已完结
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
20天前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
23天前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
24天前
已完结
Treatment of Myasthenia Gravis
27天前
已完结
Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series
27天前
已完结
Complement system activation: bridging physiology, pathophysiology, and therapy
27天前
已完结
Real-World experience with efgartigimod in patients with myasthenia gravis
27天前
已完结
Anti-CD19 CAR T cells for refractory myasthenia gravis
27天前
已完结
没有进行任何应助
感谢
13天前
感谢
13天前
感谢
20天前
感谢
24天前
感谢
27天前
感谢
27天前
感谢
27天前
感谢
27天前
感谢
29天前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论